From study websites and outreach to screening, scheduling, and site support — PatientWing manages the full recruitment journey for you.
.png)
.svg.png){kind=logo}
Your team spends less time treating patients and more time sorting through unqualified referrals.
Without warm patient handoffs and scheduling support, even qualified patients fall through the cracks.
Disjointed tools and teams hinder recruitment, reduce visibility, and inflate costs.
PatientWing offers end-to-end recruitment for sponsors who want results without operational complexity enrollment results. We do everything ourselves, from study websites and pre-screeners to phone screening, medical record collection, and site scheduling. You get one partner, one process, and complete visibility.
We design branded, IRB approved study pages with patient-friendly language, multilingual support, and digital pre-screeners that pre-qualify patients upfront.
Our in-house Patient Enrollment Center follows up with interested patients, screens them over the phone, collects their medical records, and schedules them directly with your sites.
We train your sites on our platform, coordinate handoffs, and provide weekly reporting so you always know what’s working. You get live insights into what’s working and what’s not across every step of enrollment.
Sponsors trust us to deliver across a wide range of trials. From early-phase studies and global startups to rare conditions and hard to reach populations, we build patient recruitment strategies that meet the needs of your protocol.
The chart highlights the therapeutic areas where we’ve already delivered results. No matter your indication, our process adapts to your study’s goals, timelines, and complexity.
We train your sites on our platform, coordinate handoffs, and provide weekly reporting so you always know what’s working. You get transparency, not just numbers.
23% of all enrollments in a global eosinophilic esophagitis (EoE) trial came from PatientWing.
40% of Black participants and 28.5% of Hispanic participants in a primary sclerosing cholangitis (PSC) study came from PatientWing.
PatientWing Reduced operational timelines by months, saving $8M+ in costs for a global phase II study.
Supported patient recruitment across 30+ countries and 5 Continents.
We are medical professionals, patient advocates, scientists, and strategists from around the world, all driven to solve one challenge, helping you meet your enrollment goals with speed and confidence.
It goes without saying that success seen to date for the US has been nothing short of incredible! Currently supporting 50% of current US screenings, 40% of US consents, and 40% of US randomizations – WOW WOW!!!
Rare Disease Biotech
We work with 19 vendors and PatientWing is the only company we don’t have any issues with. I plan on bringing PatientWing to my new company!
Rare Disease Biotech
PatientWing is doing an excellent job of helping patients with rare diseases, spreading awareness for them, and enrolling them in clinical trials. The engagement alone on helping people feel not alone after receiving a diagnosis that alters their life is so important.
Eosinophilic Esophagitis (EoE) Patient
Yes, We have experience in these populations across multiple studies.
Our unique outreach methods, our passionate team, and our commitment to bringing our clients success when it comes to contributing actual enrollments to their study.
Yes, Our team handles the collection and transfer process securely and compliantly.
